Injectable Naltrexone Tops Disulfiram, Acamprosate as Safer Option in Alcohol Use Disorder.Published in:Healio Gastroenterology, 2025, v. 11, n. 4, p. 33By:Jenkins, CassandraPublication type:Article
Metabolic Surgery Slashed Risk for Adverse Outcomes in MASH-Related Cirrhosis, Obesity.Published in:Healio Gastroenterology, 2025, v. 11, n. 4, p. 33By:Jenkins, CassandraPublication type:Article
FMT Safe, Linked to Reduced Hepatic Encephalopathy Recurrence in Patients With Cirrhosis.Published in:Healio Gastroenterology, 2025, v. 11, n. 4, p. 32By:Jenkins, CassandraPublication type:Article